Pregabalina (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pregabalina" in Polish language version.

refsWebsite
Global rank Polish rank
4th place
7th place
2nd place
6th place
1st place
1st place
8,738th place
165th place
924th place
75th place
399th place
2,234th place
5th place
2nd place
low place
585th place
low place
low place
low place
low place

doi.org

dx.doi.org

  • I.H. Iftikhar, L. Alghothani, L.M. Trotti, Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis, „European Journal of Neurology”, 24 (12), 2017, s. 1446–1456, DOI10.1111/ene.13449, PMID28888061 [dostęp 2021-10-20] (ang.).
  • James E. Frampton, Pregabalin: a review of its use in adults with generalized anxiety disorder, „CNS drugs”, 28 (9), 2014, s. 835–854, DOI10.1007/s40263-014-0192-0, PMID25149863 [dostęp 2021-10-20] (ang.).
  • Lindsay Parker i inni, A systematic review of pharmacoeconomic studies for pregabalin, „Pain Practice”, 15 (1), 2015, s. 82–94, DOI10.1111/papr.12193, PMID24815038 (ang.).
  • Paweł Kawalec i inni, Pregabalin for the treatment of social anxiety disorder, „Expert Opinion on Investigational Drugs”, 24 (4), 2015, s. 585–594, DOI10.1517/13543784.2014.979283, PMID25361817 (ang.).
  • Santosh Bhusal, Sherilyn Diomampo, Marina N. Magrey, Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia, „Drug, Healthcare and Patient Safety”, 8, 2016, s. 13–23, DOI10.2147/DHPS.S95535, PMID26937205, PMCIDPMC4762578 (ang.).
  • Emily Griffin, Jamie N. Brown, Pregabalin for the Treatment of Restless Legs Syndrome, „The Annals of Pharmacotherapy”, 50 (7), 2016, s. 586–591, DOI10.1177/1060028016643097, PMID27091870 (ang.).
  • Terri M. Wensel, Krystal W. Powe, Marshall E. Cates, Pregabalin for the treatment of generalized anxiety disorder, „The Annals of Pharmacotherapy”, 46 (3), 2012, s. 424–429, DOI10.1345/aph.1Q405, PMID22395254 (ang.).
  • Ole Schjerning i inni, Abuse Potential of Pregabalin: A Systematic Review, „CNS drugs”, 30 (1), 2016, s. 9–25, DOI10.1007/s40263-015-0303-6, PMID26767525 (ang.).
  • Richard B. Silverman, From Basic Science to Blockbuster Drug: The Discovery of Lyrica, „Angewandte Chemie International Edition”, 47 (19), 2008, s. 3500–3504, DOI10.1002/anie.200704280, PMID18307181 (ang.).

drugs.com

infoplanet.pl

mp.pl

indeks.mp.pl

  • Pregabalina, [w:] Indeks Leków MP, opis substancji, Medycyna Praktyczna [dostęp 2017-10-28].
  • Pregabalina, [w:] Indeks Leków MP, lista preparatów, Medycyna Praktyczna [dostęp 2020-12-16].

nih.gov

ncbi.nlm.nih.gov

  • I.H. Iftikhar, L. Alghothani, L.M. Trotti, Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis, „European Journal of Neurology”, 24 (12), 2017, s. 1446–1456, DOI10.1111/ene.13449, PMID28888061 [dostęp 2021-10-20] (ang.).
  • James E. Frampton, Pregabalin: a review of its use in adults with generalized anxiety disorder, „CNS drugs”, 28 (9), 2014, s. 835–854, DOI10.1007/s40263-014-0192-0, PMID25149863 [dostęp 2021-10-20] (ang.).
  • Lindsay Parker i inni, A systematic review of pharmacoeconomic studies for pregabalin, „Pain Practice”, 15 (1), 2015, s. 82–94, DOI10.1111/papr.12193, PMID24815038 (ang.).
  • Paweł Kawalec i inni, Pregabalin for the treatment of social anxiety disorder, „Expert Opinion on Investigational Drugs”, 24 (4), 2015, s. 585–594, DOI10.1517/13543784.2014.979283, PMID25361817 (ang.).
  • Santosh Bhusal, Sherilyn Diomampo, Marina N. Magrey, Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia, „Drug, Healthcare and Patient Safety”, 8, 2016, s. 13–23, DOI10.2147/DHPS.S95535, PMID26937205, PMCIDPMC4762578 (ang.).
  • Emily Griffin, Jamie N. Brown, Pregabalin for the Treatment of Restless Legs Syndrome, „The Annals of Pharmacotherapy”, 50 (7), 2016, s. 586–591, DOI10.1177/1060028016643097, PMID27091870 (ang.).
  • Terri M. Wensel, Krystal W. Powe, Marshall E. Cates, Pregabalin for the treatment of generalized anxiety disorder, „The Annals of Pharmacotherapy”, 46 (3), 2012, s. 424–429, DOI10.1345/aph.1Q405, PMID22395254 (ang.).
  • Ole Schjerning i inni, Abuse Potential of Pregabalin: A Systematic Review, „CNS drugs”, 30 (1), 2016, s. 9–25, DOI10.1007/s40263-015-0303-6, PMID26767525 (ang.).
  • Richard B. Silverman, From Basic Science to Blockbuster Drug: The Discovery of Lyrica, „Angewandte Chemie International Edition”, 47 (19), 2008, s. 3500–3504, DOI10.1002/anie.200704280, PMID18307181 (ang.).
  • Ryszard Andruszkiewicz, Richard B. Silverman, 4-Amino-3-alkylbutanoic acids as substrates for γ-aminobutyric acid aminotransferase, „Journal of Biological Chemistry”, 265 (36), 1990, s. 22288–22291, PMID2266125 (ang.).

pfm.pl

  • Pregabalin Sandoz, [w:] Index leków [online], Portal Farmaceutyczno-Medyczny [dostęp 2019-03-29] [zarchiwizowane z adresu 2019-03-29].

sigmaaldrich.com

viamedica.pl

journals.viamedica.pl

web.archive.org

worldcat.org